ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
N24-002,Pantoprazole,CYP2C19,"Minor â€“ result should be considered as may affect medicationresponse",NA
N24-002,Duloxetine,"CYP1A2CYP2D6",Usual prescribing considerations apply,INHIBITOR MODERATE: CYP2D6
N24-002,Quetiapine,CYP3A4,Usual prescribing considerations apply,NA
N24-002,prazosin,NA,NO,NA
N24-002, trazadone,NA,NO,NA
N24-002, valproate,NA,NO,NA
N24-002, ethinyloestradiol / levonorgestrel (Microgynon),NA,NO,INHIBITOR MODERATE: CYP1A2
